Related content

Anti-CCP Antibody Detection Facilitates Early Diagnosis and Prognosis of Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis

By Abdel-Nasser A. M.   Mahmoud M. H.   El Mansoury T. M.   Osman A. M.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 329-336

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of anti‐citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis

By Nakamura H.   Kawakami A.   Ida H.   Origuchi T.   Matsuoka N.   Tsuboi M.   Furuyama M.   Mizokami A.   Tsukada T.   Nakashima M.   Ejima E.   Hamasaki K.   Aoyagi K.   Uetani M.   Fukuda T.   Honda S.   Urayama S.   Kawabe Y.   Ueki Y.   Mine M.   Eguchi K.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 6, 2005-11 ,pp. : 489-490

Informa Healthcare

Access to resources Recommend Favorite

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori   Takahashi Masaaki   Torikai Eiji   Suzuki Motohiro   Ichikawa Tetsuya   Nagafusa Tetsuyuki   Koide Yukio   Nagano Akira  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite